The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 16,410 | 378,288 | SH | SOLE | 378,288 | 0 | 0 | ||
| ACCELERON PHARMA INC | COM | 00434H108 | 15,238 | 112,363 | SH | SOLE | 112,363 | 0 | 0 | ||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 23,531 | 548,374 | SH | SOLE | 548,374 | 0 | 0 | ||
| ARCUS BIOSCIENCES INC | COM | 03969F109 | 11,232 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| ARVINAS INC | COM | 04335A105 | 11,799 | 178,500 | SH | SOLE | 178,500 | 0 | 0 | ||
| AVIDITY BIOSCIENCES INC | COM | 05370A108 | 9,741 | 446,641 | SH | SOLE | 446,641 | 0 | 0 | ||
| CARDIFF ONCOLOGY INC | COM | 14147L108 | 6,019 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 11,565 | 561,398 | SH | SOLE | 561,398 | 0 | 0 | ||
| CHEMOCENTRYX INC | COM | 16383L106 | 7,690 | 150,076 | SH | SOLE | 150,076 | 0 | 0 | ||
| CONNECT BIOPHARMA HLDGS LTD | ADS | 207523101 | 6,910 | 373,492 | SH | SOLE | 373,492 | 0 | 0 | ||
| CURIS INC | COM NEW | 231269200 | 24,093 | 2,128,400 | SH | SOLE | 2,128,400 | 0 | 0 | ||
| DESIGN THERAPEUTICS INC | COM | 25056L103 | 7,475 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| DYNE THERAPEUTICS INC | COM | 26818M108 | 9,064 | 583,649 | SH | SOLE | 583,649 | 0 | 0 | ||
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 4,063 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| FOGHORN THERAPEUTICS INC | COM | 344174107 | 911 | 69,132 | SH | SOLE | 69,132 | 0 | 0 | ||
| GOSSAMER BIO INC | COM | 38341P102 | 13,072 | 1,413,138 | SH | SOLE | 1,413,138 | 0 | 0 | ||
| HELIX ACQUISITION CORP | COM CL A | G4444C102 | 4,080 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| I MAB | SPONSORED ADS | 44975P103 | 25,692 | 530,050 | SH | SOLE | 530,050 | 0 | 0 | ||
| IKENA ONCOLOGY INC | COM | 45175G108 | 11,300 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 4,203 | 680,036 | SH | SOLE | 680,036 | 0 | 0 | ||
| JIYA ACQUISITION CORP | COM CL A | 47760M102 | 2,952 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| KRONOS BIO INC | COM | 50107A104 | 4,278 | 146,173 | SH | SOLE | 146,173 | 0 | 0 | ||
| MERUS N V | COM | N5749R100 | 4,178 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 5,814 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| PMV PHARMACEUTICALS INC | COM | 69353Y103 | 8,223 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | 3,652 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| REVOLUTION MEDICINES INC | COM | 76155X100 | 5,787 | 126,136 | SH | SOLE | 126,136 | 0 | 0 | ||
| TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 6,505 | 320,440 | SH | SOLE | 320,440 | 0 | 0 | ||